CBRE

CBRE Group

$129.95

-1.22%
Jun 22, 2026
Bobby Quantitative Model
CBRE Group is the world's largest commercial real estate services and investment firm, providing a comprehensive suite of services including leasing, property and project management, and capital markets advisory to owners, occupants, and investors globally. The company is the dominant market leader in its industry, leveraging its unparalleled global scale, integrated platform, and a significant investment management arm that managed over $155 billion in client assets as of year-end 2025. The current investor narrative is dominated by the stock's significant underperformance relative to the broader market, driven by concerns over cyclical pressures in commercial real estate transaction volumes, capital markets activity, and the potential impact of an economic slowdown on its core service lines, as evidenced by recent sharp price declines amid a sector-wide selloff.

People also watch

CoStar Group

CoStar Group

CSGP

Analysis
Jones Lang LaSalle

Jones Lang LaSalle

JLL

Analysis
Opendoor

Opendoor

OPEN

Analysis
Welltower

Welltower

WELL

Analysis
Prologis

Prologis

PLD

Analysis

CBRE 12-Month Price Forecast

Historical Price
Current Price $129.95
Average Target $129.95
High Target $149.44249999999997
Low Target $110.45749999999998

Wall Street consensus

Most Wall Street analysts maintain a constructive view on CBRE Group's 12-month outlook, with a consensus price target around $168.94 and implied upside of +30.0% versus the current price.

Average Target

$168.94

3 analysts

Implied Upside

+30.0%

vs. current price

Analyst Count

3

covering this stock

Price Range

$104 - $169

Analyst target range

Buy
0 (0%)
Hold
1 (33%)
Sell
2 (67%)

Analyst coverage for CBRE appears limited in the provided dataset, with only 3 analysts contributing to estimates for revenue and EPS. The average revenue estimate for the forward period is $61.81 billion, with a range from $58.06 billion to $65.98 billion. The average EPS estimate is $13.35, ranging from $12.30 to $14.52. Specific consensus price targets and a Buy/Hold/Sell distribution are not provided in the data, making a precise calculation of implied upside or downside impossible. The available institutional ratings data shows a generally bullish tilt among covering firms, with recent actions including UBS upgrading from Neutral to Buy in February 2026 and Keefe, Bruyette & Woods upgrading from Market Perform to Outperform in December 2025. Other firms like Barclays and Morgan Stanley have maintained Overweight ratings. This pattern of recent upgrades suggests a building positive sentiment among analysts, likely anticipating a cyclical recovery. The wide range in revenue and EPS estimates signals a high degree of uncertainty regarding the timing and magnitude of the company's fundamental turnaround, which is typical for a cyclical business at an inflection point.

Drowning in data?

Find the real signal!

CBRE Technical Analysis

The stock is in a pronounced and sustained downtrend, having declined 18.61% over the past six months and 17.88% year-to-date as of the latest data. Currently trading at a price of $131.55, it sits near the lower end of its 52-week range of $121.69 to $174.27, indicating the stock is in a zone of potential value but remains under significant selling pressure. This positioning near the lows suggests the market is pricing in substantial fundamental headwinds, though it also presents a potential entry point for contrarian investors if the cyclical outlook stabilizes. Recent momentum shows a slight short-term bounce, with the stock up 2.65% over the past month, which contrasts sharply with its longer-term downtrend. However, this modest gain is overshadowed by a 0.33% decline over the past three months and a stark negative relative strength of -15.47% versus the S&P 500 over that period, indicating the stock's recovery attempts are weak and it continues to significantly lag the broader market's rally. Key technical support is clearly defined at the 52-week low of $121.69, while resistance lies at the recent highs near the 52-week peak of $174.27. A decisive break below the $121.69 support would signal a continuation of the bearish trend and likely lead to further downside, whereas a sustained move above the $150-$160 range would be needed to suggest a meaningful reversal. The stock's beta of 1.221 indicates it is approximately 22% more volatile than the broader market, which amplifies both downside risk and potential upside during recoveries, a critical factor for risk-aware position sizing.

Beta

1.22

1.22x market volatility

Max Drawdown

-27.4%

Largest decline past year

52-Week Range

$122-$174

Price range past year

Annual Return

-2.9%

Cumulative gain past year

PeriodCBRE ReturnS&P 500
1m-0.9%-0.2%
3m-2.2%+14.0%
6m-21.2%+7.8%
1y-2.9%+25.3%
ytd-18.9%+9.2%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

CBRE Fundamental Analysis

Revenue growth has been positive but shows signs of deceleration in the most recent quarter. Q4 2025 revenue was $11.629 billion, representing a solid 11.77% year-over-year increase. However, examining the sequential quarterly trend from the income statement reveals revenue grew from $8.91 billion in Q1 2025 to $11.629 billion in Q4, but the growth rate has been volatile, with Q4's $11.629 billion representing a decline from the prior year's Q4 revenue of $10.404 billion when comparing the same periods in the provided data. Segment data indicates the Advisory Services segment contributed $2.915 billion and Project Management contributed $2.212 billion, though these figures lack a comparative period for growth analysis. The company remains profitable but with compressed margins. Q4 2025 net income was $416 million, resulting in a net margin of 3.58%. The gross margin for the quarter was 15.29%, which is a significant compression from the 20.66% gross margin reported in Q4 2024. This margin pressure is evident in the operating margin, which fell to 1.87% in Q4 2025 from 5.71% in the year-ago quarter, indicating rising costs or a less favorable revenue mix are impacting profitability. The balance sheet shows moderate leverage with a debt-to-equity ratio of 1.125, and the company maintains a current ratio of 1.095, indicating adequate short-term liquidity. Critically, the company generates substantial free cash flow, with TTM free cash flow of $1.193 billion, providing internal funding for operations and growth. The Return on Equity (ROE) of 13.03% is respectable, suggesting efficient use of shareholder capital despite the cyclical pressures.

Quarterly Revenue

$11.6B

2025-12

Revenue YoY Growth

+0.11%

YoY Comparison

Gross Margin

+0.15%

Latest Quarter

Free Cash Flow

$1.2B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Advisory Services Segment
Project Management
Real Estate Investments Segment

Open an Account, get $2 TSLA now!

Valuation Analysis: Is CBRE Overvalued?

Given the company's positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE ratio is elevated at 41.44x, while the forward PE is significantly lower at 14.84x. This substantial gap implies the market expects a strong recovery in earnings over the next twelve months, pricing the stock based on future profitability rather than depressed current results. Compared to sector averages, the stock's valuation presents a mixed picture. Its Price-to-Sales (PS) ratio of 1.18x and EV-to-Sales of 1.17x are likely at or below the real estate services industry average, suggesting a discount based on sales. However, its elevated trailing PE indicates the market is penalizing current earnings volatility. The PEG ratio of 1.82, based on trailing earnings, suggests the stock is not cheap relative to its historical growth, factoring in the recent profit challenges. Historically, the current trailing PE of 41.44x is near the top of its own range compared to recent quarters, where it has fluctuated between approximately 14.86x (Q4 2023) and 61.35x (Q1 2025). Trading near the higher end of this recent band suggests the market has already priced in a significant earnings contraction. However, the forward PE of 14.84x is much more in line with its historical lows, indicating that if the company meets forward earnings estimates, the stock could be considered reasonably valued from a historical perspective.

PE

41.4x

Latest Quarter

vs. Historical

Mid-Range

5-Year PE Range 12x~75x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

21.7x

Enterprise Value Multiple